BioSpace News Archive

Nemaura Medical, Inc. announces the beta launch of MiBoKo, a new metabolic health program utilizing a noninvasive glucose sensor along with an AI mobile application.

Castle Creek Biosciences, Inc. today announced a research collaboration with Mayo Clinic to advance discovery and pre-clinical development of investigational gene therapy candidates for the treatment of osteogenesis imperfecta

Smart Immune SAS’s unique ex-vivo biomimetic ProTcell™ ‘thymus in a dish’ platform technology, designed to generate specific human T-cell progenitor cells at scale with high purity, homogeneity, and yield, has been reinforced by data published in the peer-reviewed journal Cellular & Molecular Immunology1.

Neurelis, Inc. announced today that it is presenting two posters at the 50th Annual Meeting of the Child Neurology Society in Boston from September 29 through October 2.

Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer Research (AACR) Special Conference on Pancreatic Cancer.

A groundbreaking study shows that a new rapid test identifies COVID-19 patients who will deteriorate with greater accuracy than existing tests, thus helping patients to get life-saving treatment.

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced the launch of the InVictus OsseoScrew Expandable Spinal Fixation System.

The couple’s gift, one of the largest in City of Hope’s history, comes 14 years after James “Jim” Belardi received a lifesaving bone marrow transplant at the cancer center.

NASS 36th ANNUAL MEETING - Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code specifically for vertebrogenic low back pain.

Two new studies presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how antibodies against the SARS-CoV-2 virus can vary among recipients of different COVID-19 vaccines and naturally infected individuals.